Intuitive Surgical (NASDAQ:ISRG) Price Target Raised to $650.00 at Royal Bank Of Canada

Intuitive Surgical (NASDAQ:ISRG) had its price objective increased by Royal Bank Of Canada from $625.00 to $650.00 in a report issued on Wednesday, Marketbeat reports. They currently have an outperform rating on the medical equipment provider’s stock.

A number of other brokerages have also recently issued reports on ISRG. Robert W. Baird set a $655.00 price objective on shares of Intuitive Surgical in a report on Wednesday, October 22nd. Leerink Partners increased their price objective on Intuitive Surgical from $593.00 to $600.00 and gave the company an “outperform” rating in a report on Wednesday, October 22nd. The Goldman Sachs Group raised their price objective on Intuitive Surgical from $567.00 to $621.00 and gave the company a “buy” rating in a research note on Wednesday, October 22nd. Raymond James Financial set a $603.00 target price on Intuitive Surgical and gave the stock an “outperform” rating in a research report on Wednesday, October 22nd. Finally, Deutsche Bank Aktiengesellschaft reissued a “sell” rating on shares of Intuitive Surgical in a research report on Friday, August 22nd. Two equities research analysts have rated the stock with a Strong Buy rating, sixteen have given a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $609.83.

Intuitive Surgical Stock Performance

Shares of ISRG opened at $556.86 on Wednesday. The firm has a market cap of $199.62 billion, a PE ratio of 73.66, a PEG ratio of 5.10 and a beta of 1.68. The firm’s 50 day moving average price is $536.26 and its 200 day moving average price is $505.77. Intuitive Surgical has a twelve month low of $425.00 and a twelve month high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, topping the consensus estimate of $1.99 by $0.41. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The company had revenue of $2.51 billion during the quarter, compared to the consensus estimate of $2.41 billion. During the same period in the previous year, the firm posted $1.84 earnings per share. The company’s revenue for the quarter was up 22.9% compared to the same quarter last year. On average, sell-side analysts anticipate that Intuitive Surgical will post 6.43 earnings per share for the current fiscal year.

Insider Buying and Selling

In other news, EVP Henry L. Charlton sold 13,731 shares of the firm’s stock in a transaction on Wednesday, November 12th. The shares were sold at an average price of $580.00, for a total value of $7,963,980.00. Following the sale, the executive vice president owned 3,056 shares in the company, valued at approximately $1,772,480. This trade represents a 81.80% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Craig H. Barratt sold 750 shares of the business’s stock in a transaction on Wednesday, November 12th. The stock was sold at an average price of $580.00, for a total transaction of $435,000.00. The SEC filing for this sale provides additional information. Insiders sold 114,007 shares of company stock valued at $63,533,844 in the last ninety days. Company insiders own 0.70% of the company’s stock.

Institutional Investors Weigh In On Intuitive Surgical

Several hedge funds have recently made changes to their positions in the stock. Brighton Jones LLC increased its stake in Intuitive Surgical by 24.9% during the fourth quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock valued at $1,916,000 after acquiring an additional 731 shares during the period. Colonial Trust Advisors grew its holdings in shares of Intuitive Surgical by 5,000.0% during the 1st quarter. Colonial Trust Advisors now owns 102 shares of the medical equipment provider’s stock worth $51,000 after purchasing an additional 100 shares in the last quarter. Van Lanschot Kempen Investment Management N.V. grew its holdings in shares of Intuitive Surgical by 28.0% during the 1st quarter. Van Lanschot Kempen Investment Management N.V. now owns 30,635 shares of the medical equipment provider’s stock worth $15,173,000 after purchasing an additional 6,702 shares in the last quarter. Vertex Planning Partners LLC increased its position in shares of Intuitive Surgical by 5.3% during the first quarter. Vertex Planning Partners LLC now owns 896 shares of the medical equipment provider’s stock valued at $444,000 after purchasing an additional 45 shares during the period. Finally, Erste Asset Management GmbH raised its stake in shares of Intuitive Surgical by 6.5% in the first quarter. Erste Asset Management GmbH now owns 104,057 shares of the medical equipment provider’s stock valued at $51,898,000 after purchasing an additional 6,381 shares in the last quarter. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.